0001140361-18-019388.txt : 20180424
0001140361-18-019388.hdr.sgml : 20180424
20180424163040
ACCESSION NUMBER: 0001140361-18-019388
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180420
FILED AS OF DATE: 20180424
DATE AS OF CHANGE: 20180424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kunkel Lori Anne
CENTRAL INDEX KEY: 0001536368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36562
FILM NUMBER: 18771755
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Loxo Oncology, Inc.
CENTRAL INDEX KEY: 0001581720
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462996673
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 281 TRESSER BOULEVARD, 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06901
BUSINESS PHONE: 203-653-3880
MAIL ADDRESS:
STREET 1: 281 TRESSER BOULEVARD, 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06901
4
1
doc1.xml
FORM 4
X0306
4
2018-04-20
0
0001581720
Loxo Oncology, Inc.
LOXO
0001536368
Kunkel Lori Anne
C/O LOXO ONCOLOGY, INC.
281 TRESSER BLVD, 9TH FLOOR
STAMFORD
CT
06901
1
0
0
0
Common Stock
2018-04-20
4
S
0
900
131.9772
D
10940
D
Common Stock
2018-04-20
4
S
0
4000
132.8097
D
6940
D
Common Stock
2018-04-20
4
S
0
100
133.60
D
6840
D
The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 20, 2017.
Represents the aggregate of sales effected on the same day at different prices.
Represents the weighted average sales price per share. The shares sold at prices ranging from $131.22 to $132.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $132.55 to $133.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
/s/ Jennifer Burstein, by power of attorney
2018-04-24